BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25729328)

  • 1. EGF +61A/G polymorphism contributes to increased gastric cancer risk: evidence from a meta-analysis.
    Peng Q; Li S; Qin X; Lao X; Chen Z; Zhang X; Chen J
    Cancer Cell Int; 2014; 14():134. PubMed ID: 25729328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between epidermal growth factor gene +61A/G polymorphism and the risk of hepatocellular carcinoma: a meta-analysis based on 16 studies.
    Jiang G; Yu K; Shao L; Yu X; Hu C; Qian P; Xie H; Li J; Zheng J; Zheng S
    BMC Cancer; 2015 Apr; 15():314. PubMed ID: 25927412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGF +61A>G polymorphism and gastrointestinal cancer risk: a HuGE review and meta-analysis.
    Piao Y; Liu Z; Ding Z; Xu L; Guo F; Sun Q; Xie X
    Gene; 2013 Apr; 519(1):26-33. PubMed ID: 23403233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of association between EGF +61A>G polymorphism and melanoma susceptibility in Caucasians: a HuGE review and meta-analysis.
    Wu D; Wu Y; Zhang X; Cong P; Lv X
    Gene; 2013 Feb; 515(2):359-66. PubMed ID: 23201894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative assessment of the effect of epidermal growth factor 61A/G polymorphism on the risk of hepatocellular carcinoma.
    Shen XF; Zeng XT; Jian ZY; Zhou M; Zhou P; Zhang M
    Oncol Lett; 2015 Nov; 10(5):3199-3205. PubMed ID: 26722312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between the EGF rs4444903 polymorphism and liver cancer susceptibility: a meta-analysis and meta-regression.
    Li YL; Tian Z; Zhao L; Zhang CL
    Genet Mol Res; 2014 Oct; 13(4):8066-79. PubMed ID: 25299191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative assessment of the association between +61A>G polymorphism of epidermal growth factor gene and susceptibility to glioma.
    Tao Y; Liang G
    Tumour Biol; 2014 Jan; 35(1):369-77. PubMed ID: 23963773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between cyclin D1 G870A polymorphism and hepatocellular carcinoma risk: a meta-analysis.
    Luo T; Chen J; Liu JJ; Li H; You XM; Wang HL; Zhu SL; Li LQ
    Onco Targets Ther; 2016; 9():4483-9. PubMed ID: 27499641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between the risk of hepatitis virus-related hepatocellular carcinoma and EGF polymorphism: A PRISMA-compliant updated meta-analysis.
    Wang Q; Xu L; Wu Q; Zhang M; Zhang J
    Medicine (Baltimore); 2022 Oct; 101(42):e31280. PubMed ID: 36281156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-12B+1188A/C polymorphism contributes to increased hepatocellular carcinoma susceptibility: evidence from a meta-analysis.
    Peng Q; Li S; Lao X; Chen Z; Li R; Qin X
    Clin Res Hepatol Gastroenterol; 2014 Dec; 38(6):735-43. PubMed ID: 25445750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between EGF +61 A>G polymorphism and gastric cancer risk: A meta-analysis.
    Wu SJ; Jiang SY; Wu J; Xiong GL
    J Huazhong Univ Sci Technolog Med Sci; 2015 Jun; 35(3):327-332. PubMed ID: 26072068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between EGF +61A/G polymorphism and gastric cancer in Caucasians.
    Araújo AP; Costa BM; Pinto-Correia AL; Fragoso M; Ferreira P; Dinis-Ribeiro M; Costa S; Reis RM; Medeiros R
    World J Gastroenterol; 2011 Jan; 17(4):488-92. PubMed ID: 21274378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between epidermal growth factor gene rs4444903 polymorphism and risk of glioma.
    Hu M; Shi H; Xu Z; Liu W
    Tumour Biol; 2013 Jun; 34(3):1879-85. PubMed ID: 23645212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGF+61 A>G polymorphism does not predict response to first-generation EGFR tyrosine kinase inhibitors in lung cancer patients.
    Leal LF; Laus AC; Cavagna R; de Paula FE; de Oliveira MA; Ribeiro DM; Hassan FM; Miziara JE; da Silva ECA; da Silva VD; De Marchi P; Reis RM
    Thorac Cancer; 2020 Oct; 11(10):2987-2992. PubMed ID: 32881389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of epidermal growth factor polymorphisms and cancer risk: involving 9,779 cases and 15,932 controls.
    Li TF; Ren KW; Liu PF
    DNA Cell Biol; 2012 Apr; 31(4):568-74. PubMed ID: 22070650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the interleukin-10 gene polymorphism (-1082A/G) with systemic lupus erythematosus: a meta-analysis.
    Zhou M; Ding L; Peng H; Wang B; Huang F; Xu WD; Li JH; Ye XR; Pan HF; Ye DQ
    Lupus; 2013 Feb; 22(2):128-35. PubMed ID: 23192326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single Nucleotide Polymorphisms in
    Li X; Li X; Jiang M; Tian W; Zhou B
    Front Oncol; 2018; 8():613. PubMed ID: 30619753
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of the epidermal growth factor gene +61A>G polymorphism with hepatocellular carcinoma in an Iranian population.
    Gholizadeh M; Khosravi A; Torabian P; Gholipoor N; Mansour Samaei N
    Gastroenterol Hepatol Bed Bench; 2017; 10(4):284-288. PubMed ID: 29379593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between ATM rs1801516 polymorphism and cancer susceptibility: a meta-analysis involving 12,879 cases and 18,054 controls.
    Gu Y; Shi J; Qiu S; Qiao Y; Zhang X; Cheng Y; Liu Y
    BMC Cancer; 2018 Nov; 18(1):1060. PubMed ID: 30384829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The PD-1 rs36084323 A > G polymorphism decrease cancer risk in Asian: A meta-analysis.
    Da LS; Zhang Y; Zhang CJ; Bu LJ; Zhu YZ; Ma T; Gu KS
    Pathol Res Pract; 2018 Nov; 214(11):1758-1764. PubMed ID: 30249505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.